Trials / Completed
CompletedNCT01711281
Monitoring of Hemodynamics in Heart Failure Patients by Intracardiac Impedance Measurement
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- Biotronik SE & Co. KG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Heart Failure (HF) is one of the most frequent diagnoses upon hospitalization and is a major cause of death. Cardiac resynchronization therapy (CRT) using an implantable device for synchronous bi-ventricular stimulation leads to improvement of hemodynamic parameters, physical capacity and quality of life. A continuous measurement of the left-ventricular volume would provide information about heart performance and could be used for both heart failure monitoring and optimization of CRT-therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Intracardiac Impedance Measurement Algorithm (integrated in CRT-D device) |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2015-06-01
- First posted
- 2012-10-22
- Last updated
- 2015-07-15
Locations
22 sites across 5 countries: Denmark, Germany, Italy, Netherlands, Switzerland
Source: ClinicalTrials.gov record NCT01711281. Inclusion in this directory is not an endorsement.